Combination treatment for Hep C associated with favorable response among patients with HIV

(The JAMA Network Journals) HIV-infected patients also infected with hepatitis C virus who received a combination of the medications sofosbuvir plus ribavirin had high rates of sustained HCV virologic response 12 weeks after cessation of therapy, according to a study in the July 23/30 issue of JAMA, a theme issue on HIV/AIDS.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news